Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis
| Autor: | Stewart, Paul, Blanchette, Phillip, Shah, Prakesh S., Ye, Xiang Y., Boldt, R. Gabriel, Fernandes, Ricardo, Vandenberg, Ted, Raphael, Jacques |
|---|---|
| Zdroj: | In The Breast December 2020 54:203-210 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect